Integrative Analysis of Novel Metabolic Subtypes in Pancreatic Cancer Fosters New Prognostic Biomarkers

Background: Most of the patients with Pancreatic Ductal Adenocarcinoma (PDA) are not eligible for a curative surgical resection. For this reason there is an urgent need for personalized therapies. PDA is the result of complex interactions between tumor molecular profile and metabolites produced by i...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Front Oncol
Egile Nagusiak: Follia, Laura, Ferrero, Giulio, Mandili, Giorgia, Beccuti, Marco, Giordano, Daniele, Spadi, Rosella, Satolli, Maria Antonietta, Evangelista, Andrea, Katayama, Hiroyuki, Hong, Wang, Momin, Amin A., Capello, Michela, Hanash, Samir M., Novelli, Francesco, Cordero, Francesca
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Frontiers Media S.A. 2019
Gaiak:
Oncology
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6400843/
https://ncbi.nlm.nih.gov/pubmed/30873387
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2019.00115
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak